Guillain-Barre Syndrome was a "very rare" side effect, occurring in under one in 10,000 people, it added. The disorder is a nerve inflammation that may cause temporary paralysis and difficulty breathing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jXBXSA
via IFTTT
0 comments:
Post a Comment